HeroSupport

What HeroSupport does

HeroSupport SA is a Swiss medical device company that develops personalized 3D-printed immobilization devices and imaging tables for cancer radiotherapy, with a current focus on breast cancer treatment in the prone position. Its lead product, the VENUS Shell, is a patient-specific shell manufactured via additive manufacturing from medical-grade plastic (the same polymer family as LEGO bricks), designed to fit each patient's body and breast anatomy to enable precise, reproducible positioning during radiation therapy. The companion Patented Imaging Table incorporates large-field-of-view transparencies that allow 3D surface scanning of patient posture, forming the data input for manufacturing each custom shell. Together, the two products form an integrated patient-positioning workflow intended to reduce radiation exposure to the heart and lungs, shorten treatment duration, and improve patient comfort and reproducibility.

HeroSupport commercializes through direct enterprise sales to radiation oncology centers and, more recently, through exclusive regional distribution partnerships, with ELSE Solutions appointed as the Italian distributor for VENUS Shell. The company is a spin-off from Geneva University Hospital (HUG), where it conducted seven years of clinical validation, and it is now deploying in Swiss Medical Network hospitals including Clinique de Genolier and Clinique Générale-Beaulieu. Following CE Mark certification in March 2026, the company is authorized to market VENUS Shell across the European Union and Switzerland, with the United States and Australia cited as longer-term target markets.

The revenue model is anchored on hardware sales of personalized medical devices to hospitals and radiation oncology centers. Pricing is not publicly disclosed, and commercial revenue is at an early stage given the recent regulatory clearance. The go-to-market combines enterprise field sales, channel partnerships (ELSE Solutions in Italy), and event-driven promotion through major radiation oncology congresses such as ASTRO, ESTRO, and SASRO, supported by scientific publications that establish clinical credibility among specialist buyers.

Name

HeroSupport

Legal name

HeroSupport SA

Website

https://herosupport.care

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

HeroSupport SA is a Swiss MedTech spin-off from Geneva University Hospital that develops personalized 3D-printed immobilization devices (VENUS Shell) and a patented imaging table for precise, reproducible positioning during breast cancer radiotherapy, sold to hospitals and radiation oncology centers in Europe.

Ownership category

akta.pro rank

Product category

Radiation Oncology Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

akta.pro secondary industries

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Women’s Imaging & Breast Health Centers (HLAFAJAJ)

Keywords

• 3D printed medical devices
• Radiotherapy positioning systems
• Patient immobilization devices
• Breast cancer treatment
• Personalized medical devices

Headquarters

HQ city

Veyrier

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of VENUS Shell personalized immobilization devices and related imaging/treatment tables to radiation oncology centers and hospitals. Following CE Mark certification (March 2026), the company is authorized for marketing across the European Union and Switzerland.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Core offering

HeroSupport develops and sells personalized 3D-printed immobilization devices (VENUS Shell™) and a patented Imaging Table that transform standard imaging and treatment tables into patient-specific solutions. Each VENUS Shell is custom-manufactured from medical-grade plastic based on a 3D surface scan of the individual patient, enabling precise prone-position positioning during breast cancer radiotherapy. The patented Imaging Table works in combination with VENUS Shell to capture patient anatomy and reproduce positioning across simulation and treatment sessions.

Product overview

HeroSupport is a MedTech company offering two core products for breast cancer radiotherapy: the VENUS Shell™ (a patient-specific 3D-printed immobilization device) and a patented Imaging Table. The Imaging Table is used in combination with the VENUS Shell™ — the table captures patient anatomy via 3D surface scanning, which is then used to manufacture the personalized shell that ensures consistent, precise positioning throughout the radiotherapy treatment workflow. Both products are designed to work together as a complete patient-positioning solution for prone breast cancer radiotherapy.

Differentiator

Problem solved

Functional benefit

Brands

• VENUS Shell™: Patient-specific 3D-printed immobilization device designed for breast cancer radiotherapy, providing precise positioning for improved treatment accuracy, reduced radiation exposure to healthy tissues, enhanced patient comfort, and shorter treatment times.

Products and services

• VENUS Shell™ Patient-specific 3D-printed immobilization device designed for breast cancer radiotherapy in the prone position. Each device is custom-manufactured from a patient's anatomical model using surface scanning and additive manufacturing in medical-grade plastic, intended to ensure precise and reproducible positioning, reduce radiation exposure to healthy tissues (heart and lungs), enhance patient comfort, and shorten treatment duration.
• Imaging Table

Quantifiable outcome

• Reduces radiation exposure to heart and lungs compared to standard supine position
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Geneva University Hospital (HUG)coreStrategic or Co-development PartnerHeroSupport is a spin-off from HUG with seven years of collaborative research and clinical validation. HUG conducted clinical studies for VENUS Shell testing on patients with and without breast implants and those who had undergone surgery.
• Swiss Medical NetworkcoreStrategic or Co-development PartnerStrategic partnership with Swiss Medical Network including Radio-Oncology Centre at Clinique de Genolier and Clinique Générale-Beaulieu for clinical deployment of VENUS Shell. Prof. Oscar Matzinger, CMO of Swiss Medical Network, expressed strong support for bringing the solution into clinical use.
• ELSE SolutionscoreChannel Partner/ Reseller/ DistributorItalian company established in 1990, specializing in radiotherapy, nuclear medicine, radiodiagnostics, and radioprotection equipment and services. Appointed as HeroSupport's exclusive Italian distributor for VENUS Shell, jointly presenting at AIRO Congress and supporting Italian market entry.
• SwissnexminorGTM or Marketing PartnerParticipation in Swissnex Boston/NY Startup Camp November 2025, powered by Innosuisse, as part of nine-company delegation representing Switzerland's medical innovation strength. CEO pitched at Medtech Pitchfest 2025.
• EPFL (École Polytechnique Fédérale de Lausanne)minorGTM or Marketing PartnerCEO Giovanna Dipasquale participated in EPFL Investor Day 2025 in Lausanne, engaging with investors, industry leaders, and innovation ecosystem for growth strategy discussions.
• BioAlpsminorGTM or Marketing PartnerCo-organizer of FemTech leadership innovation events including deep dive on leadership in FemTech innovation at Campus Biotech Geneva, bringing together founders, investors, and industry experts.
• Healthcare Businesswomen's Association (HBA)minorGTM or Marketing PartnerCo-organizer of FemTech leadership events with BioAlps and CSEM, promoting women-led innovation and entrepreneurship in healthcare.

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Qfix: Specializes in radiotherapy patient positioning and immobilization devices (head, breast, body), including dedicated prone breast solutions. Directly overlaps with HeroSupport's VENUS Shell in indication and use case.
• CIVCO Radiotherapy: Supplies patient positioning, immobilization, and motion-management devices for radiation oncology. Competes head-to-head in breast and body radiotherapy positioning.
• Orfit Industries: Provides thermoplastic masks, immobilization systems and patient-positioning hardware for radiotherapy, including breast and thorax indications. Direct competitor in the patient-immobilization niche.
• Klarity Medical Products: Manufactures radiotherapy positioning and immobilization devices (vacuum bags, base plates, breast boards). Comparable hardware offering and customer base to HeroSupport.
• Macromedics: Develops patient positioning and immobilization systems for radiation therapy, including breast and head/neck boards. Competes with VENUS Shell on indication-specific positioning hardware.

Broad incumbents

• Brainlab: Large medtech incumbent offering integrated radiotherapy positioning, surface-guided RT, and treatment-planning software ecosystems. Adjacent positioning technology competes with HeroSupport's imaging-table approach.
• Varian (Siemens Healthineers): Global radiotherapy hardware and software leader (linacs, SGRT, treatment planning). Competes indirectly via integrated treatment couches, SGRT auto-positioning and partner immobilization ecosystems.
• Elekta: Major radiation therapy equipment vendor providing linacs and brachytherapy systems with integrated patient positioning. Competes as a full-suite incumbent that could bundle competing positioning solutions.

Emerging players

• Sun Nuclear (Mirion Healthcare): Provides patient QA, dosimetry and surface-guided radiotherapy tools. A former Sun Nuclear employee is on HeroSupport's team; product overlap is partial, focused on QA and motion management around positioning.
• Bionix Radiation Therapy: Niche manufacturer of radiotherapy positioning, immobilization and motion-management accessories for radiation oncology departments. Comparable scale and product focus to HeroSupport.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/herosupport-sa

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds7 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeroSupport